SS-31 (Elamipretide): The Mitochondria Peptide That Became a Real Drug
SS-31, now called elamipretide, targets the mitochondria and became an FDA-approved drug for a rare disease in 2025. Here is an honest look at what it does, what that approval does and does not mean, and the open questions.